langue originale | Anglais |
---|---|
Pages (de - à) | 102-104 |
Nombre de pages | 3 |
journal | European Journal of Cancer |
Volume | 149 |
Les DOIs | |
état | Publié - 1 mai 2021 |
Accès au document
Autres fichiers et liens
Contient cette citation
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Dans: European Journal of Cancer, Vol 149, 01.05.2021, p. 102-104.
Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs
TY - JOUR
T1 - High levels of TNFα in patients with COVID-19 refractory to tocilizumab
AU - Danlos, F. X.
AU - Ackermann, F.
AU - Rohmer, J.
AU - Roumier, M.
AU - Marabelle, A.
AU - Michot, J. M.
N1 - Funding Information: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Over the last 5 years, AM and JMM have participated as principal investigators and sub-investigators of oncology clinical trials sponsored by manufacturers of anti-IL6 and anti-IL6R therapies Roche/Genentech, Sanofi/Regeneron, J&J/Janssen. AM has received honoraria from Roche / Genentech, J&J and Sanofi for consulting in the field of cancer immunotherapy. AM has received grants for oncology research from Sanofi. Gustave Roussy has received funding, grants and drug supply from Roche / Genentech, Sanofi / Regeneron, Janssen for running clinical trials or research projects in oncology. FXD, FA, JR and MR have no conflict of interest to disclose.We would like to thank the following collaborators for their effort during this Covid19 crisis and their contribution to the generation, collection and analysis of our dataset: Dr Laurence Albiges, Dr Fanny Pommeret, Dr Emeline Colomba, Dr Lisa de Rosa, Pr Laurence Zitvogel, Pr Guido Kroemer, Dr Marc Vasse, Dr Christophe Willekens, Dr Antoine Hollebecque, Delphine Bredel, Dr Thomas Hueso, Severine Mouraud, Chifaou Mohamed-Djalim, Dr Giulia Baciarello, Prof Benjamin Besse, Prof Fabrice Barlesi, Prof Fabrice André, Prof Jean-Charles Soria. This work could have been done thanks to the funding support of Fondation Philanthropia, Gustave Roussy Cancer Center and Fondation Gustave Roussy. Funding Information: We would like to thank the following collaborators for their effort during this Covid19 crisis and their contribution to the generation, collection and analysis of our dataset: Dr Laurence Albiges, Dr Fanny Pommeret, Dr Emeline Colomba, Dr Lisa de Rosa, Pr Laurence Zitvogel, Pr Guido Kroemer, Dr Marc Vasse, Dr Christophe Willekens, Dr Antoine Hollebecque, Delphine Bredel, Dr Thomas Hueso, Severine Mouraud, Chifaou Mohamed-Djalim, Dr Giulia Baciarello, Prof Benjamin Besse, Prof Fabrice Barlesi, Prof Fabrice André, Prof Jean-Charles Soria. This work could have been done thanks to the funding support of Fondation Philanthropia , Gustave Roussy Cancer Center and Fondation Gustave Roussy .
PY - 2021/5/1
Y1 - 2021/5/1
UR - http://www.scopus.com/inward/record.url?scp=85104060645&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2021.01.056
DO - 10.1016/j.ejca.2021.01.056
M3 - Letter
C2 - 33848711
AN - SCOPUS:85104060645
SN - 0959-8049
VL - 149
SP - 102
EP - 104
JO - European Journal of Cancer
JF - European Journal of Cancer
ER -